Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser, and may not function properly. More information here...
    Allergy. 2011 Mar;66(3):351-9. doi: 10.1111/j.1398-9995.2010.02483.x. Epub 2010 Sep 9.

    Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation.

    Source

    Department of Life Science, Pohang University of Science and Technology (POSTECH), Pohang, Seoul, Korea.

    Abstract

    BACKGROUND:

    Recently, we found that Staphylococcus aureus produces extracellular vesicles (EV) that contain pathogenic proteins. Although S. aureus infection has been linked with atopic dermatitis (AD), the identities of the causative agents from S. aureus are controversial. We evaluated whether S. aureus-derived EV are causally related to the pathogenesis of AD.

    METHODS:

    Extracellular vesicles were isolated by the ultracentrifugation of S. aureus culture media. The EV were applied three times per week to tape-stripped mouse skin. Inflammation and immune dysfunction were evaluated 48 h after the final application in hairless mice. Extracellular vesicles-specific IgE levels were measured by ELISA in AD patients and healthy subjects.

    RESULTS:

    The in vitro application of S. aureus EV increased the production of pro-inflammatory mediators (IL-6, thymic stromal lymphopoietin, macrophage inflammatory protein-1α, and eotaxin) by dermal fibroblasts. The in vivo application of S. aureus EV after tape stripping caused epidermal thickening with infiltration of the dermis by mast cells and eosinophils in mice. These changes were associated with the enhanced cutaneous production of IL-4, IL-5, IFN-γ, and IL-17. Interestingly, the serum levels of S. aureus EV-specific IgE were significantly increased in AD patients relative to healthy subjects.

    CONCLUSION:

    These results indicate that S. aureus EV induce AD-like inflammation in the skin and that S. aureus-derived EV are a novel diagnostic and therapeutic target for the control of AD.

    © 2010 John Wiley & Sons A/S.

    PMID:
    20831718
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3052535
    Free PMC Article

    Images from this publication.See all images (6) Free text

    Figure 1
    Figure 3
    Figure 5
    Figure 2
    Figure 4
    Figure 6

      Supplemental Content

      Icon for Blackwell Publishing Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk